American Healthcare REIT Insider Award Adds 3,042 Shares to Holdings

Q: At what price were the AHR shares granted to Valerie Richardson?

The restricted shares were granted at $0 , reflecting a compensation award rather than a purchase.

Q: When do the newly granted AHR restricted shares vest?

All 3,042 shares vest on June 25, 2026 .

Q: How many AHR shares does Valerie Richardson own after the transaction?

She now beneficially owns 18,062 common shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

American Healthcare REIT, Inc. (AHR) filed a Form 4 disclosing that director Valerie Richardson received an equity grant on 25 June 2025.

Transaction: 3,042 shares of restricted common stock were awarded (coded “A”) at a price of $0.
Vesting schedule: The shares vest in full on 25 June 2026.
Post-transaction ownership: Richardson now beneficially owns 18,062 common shares, held directly.

The filing reflects routine board compensation rather than an open-market purchase. While it slightly increases insider ownership, the size of the award is modest and does not materially change overall share count or insider control.

Positive

Increase in insider ownership: Director’s holdings rose to 18,062 shares, modestly improving board-shareholder alignment.

Negative

None.

Insights

TL;DR: Routine director stock grant; modest alignment, minimal market impact.

The Form 4 shows an automatic grant of 3,042 restricted shares to Valerie Richardson upon re-election to the board. With a one-year vesting cliff and a zero cost basis, this is standard board compensation and does not signal active insider buying conviction. Richardson’s total holdings rise to 18,062 shares, which is not a significant percentage of AHR’s outstanding shares. Therefore, the disclosure is neutral for valuation and liquidity considerations.

Insider Trade Summary

Net Buyer: 3,042 shares

Net Buy 1 txn

Insider Richardson Valerie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,042	$0.00	$0.00

Holdings After Transaction: Common Stock — 18,062 shares (Direct)

Footnotes (1)

F1. Upon her re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 06/27/2025 - 04:23 PM

FAQ

What did the Form 4 for AHR dated 06/25/2025 report?

Director Valerie Richardson received 3,042 restricted common shares of American Healthcare REIT, Inc.

At what price were the AHR shares granted to Valerie Richardson?

The restricted shares were granted at $0, reflecting a compensation award rather than a purchase.

When do the newly granted AHR restricted shares vest?

All 3,042 shares vest on June 25, 2026.

How many AHR shares does Valerie Richardson own after the transaction?

She now beneficially owns 18,062 common shares.

Is this Form 4 likely to influence AHR’s stock price?

The filing is routine board compensation and considered neutral; material market impact is unlikely.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Richardson Valerie

(Last)

(First)

(Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE

92612

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/25/2025		A		3,042⁽¹⁾	A	$0	18,062	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Upon her re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.

Remarks:

	/s/ VALERIE RICHARDSON	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR